Ahmed H. Elmenoufy
Ahmed H. Elmenoufy
PhD scholar in Chem. at Uni of Alberta, Canada ..RA in Nanomedicine, China...L/A of Pharm. Chem
Verified email at ualberta.ca - Homepage
Title
Cited by
Cited by
Year
Nanocomposite‐based photodynamic therapy strategies for deep tumor treatment
J Hu, Y Tang, AH Elmenoufy, H Xu, Z Cheng, X Yang
Small 11 (44), 5860-5887, 2015
2002015
Highly Efficient FRET System Capable of Deep Photodynamic Therapy Established on X-ray Excited Mesoporous LaF3:Tb Scintillating Nanoparticles
Y Tang, J Hu, AH Elmenoufy, X Yang
ACS applied materials & interfaces 7 (22), 12261-12269, 2015
1102015
A novel deep photodynamic therapy modality combined with CT imaging established via X-ray stimulated silica-modified lanthanide scintillating nanoparticles
AH Elmenoufy, J Hu, H Xu, X Yang
Chemical Communications 51 (61), 12247-12250, 2015
602015
Computer‐aided drug design of small molecule inhibitors of the ERCC1‐XPF protein–protein interaction
F Gentile, AH Elmenoufy, G Ciniero, D Jay, F Karimi‐Busheri, KH Barakat, ...
Chemical biology & drug design 95 (4), 460-471, 2020
82020
Targeting DNA repair in tumor cells via inhibition of ERCC1–XPF
AH Elmenoufy, F Gentile, D Jay, F Karimi-Busheri, X Yang, OM Soueidan, ...
Journal of medicinal chemistry 62 (17), 7684-7696, 2019
82019
“Pyridopyridazine”: A Versatile Nucleus in Pharmaceutical Field
MA Ibrahim, AH Elmenoufy, M Elagawany, MM Ghoneim, A Moawad
Journal of Biosciences and Medicines 3 (10), 59, 2015
52015
Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1–XPF-mediated DNA repair
G Ciniero, AH Elmenoufy, F Gentile, M Weinfeld, MA Deriu, FG West, ...
Cancer Chemotherapy and Pharmacology 87 (2), 259-267, 2021
22021
Design, synthesis and in vitro cell-free/cell-based biological evaluations of novel ERCC1-XPF inhibitors targeting DNA repair pathway
AH Elmenoufy, F Gentile, D Jay, F Karimi-Busheri, X Yang, OM Soueidan, ...
European Journal of Medicinal Chemistry 204, 112658, 2020
22020
Recent Advances in Structure-Based Protein Engineering
MM Rahman, I Sarker, AH Elmenoufy, HS Bahlol, S Zaman
Scholars Journal of Applied Medical Science 3, 1224-37, 2015
12015
Targeting cancer drug resistance by modulation of ERCC1-XPF and p53 activity
G Ciniero, F Gentile, AH Elmenoufy, E Cros-Perrial, FG West, M Weinfeld, ...
Biomedical Science and Engineering 4 (s1), 2021
2021
Design, Synthesis, and Biological Evaluation of Compounds for DNA Targeted Therapy
AHM Elmenoufy
2020
Supporting Information Targeting DNA Repair in Tumor Cells via Inhibition of ERCC1-XPF
AH Elmenoufy, F Gentile, D Jay, F Karimi-Busheri, X Yang, OM Soueidan, ...
Bypassing cancer drug resistance mechanisms by tuning ERCC1-XPF and p53 activity
G Ciniero, F Gentile, AH Elmenoufy, E Cros-Perrial, FG West, M Weinfeld, ...
CANCERTO-NANOSCIENCE IN CANCER IMMUNOTHERAPY, 63, 0
The system can't perform the operation now. Try again later.
Articles 1–13